FI924368A0 - Expression av heterologiskt protein i jaest. - Google Patents

Expression av heterologiskt protein i jaest.

Info

Publication number
FI924368A0
FI924368A0 FI924368A FI924368A FI924368A0 FI 924368 A0 FI924368 A0 FI 924368A0 FI 924368 A FI924368 A FI 924368A FI 924368 A FI924368 A FI 924368A FI 924368 A0 FI924368 A0 FI 924368A0
Authority
FI
Finland
Prior art keywords
expression
jaest
heterologiskt
protein
antigens
Prior art date
Application number
FI924368A
Other languages
English (en)
Other versions
FI924368A (fi
FI104981B (fi
Inventor
Jeffrey John Clare
Michael Anthony Romanos
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10673740&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI924368(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of FI924368A publication Critical patent/FI924368A/fi
Publication of FI924368A0 publication Critical patent/FI924368A0/fi
Application granted granted Critical
Publication of FI104981B publication Critical patent/FI104981B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
FI924368A 1990-04-02 1992-09-29 Menetelmä pertaktiiniantigeenin tuottamiseksi ja sitä ilmentävä Pichia-mikro-organismi FI104981B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9007416 1990-04-02
GB909007416A GB9007416D0 (en) 1990-04-02 1990-04-02 Expression of heterologous protein in yeast
PCT/GB1991/000487 WO1991015571A1 (en) 1990-04-02 1991-03-28 Expression of heterologous protein in yeast
GB9100487 1991-03-28

Publications (3)

Publication Number Publication Date
FI924368A FI924368A (fi) 1992-09-29
FI924368A0 true FI924368A0 (fi) 1992-09-29
FI104981B FI104981B (fi) 2000-05-15

Family

ID=10673740

Family Applications (1)

Application Number Title Priority Date Filing Date
FI924368A FI104981B (fi) 1990-04-02 1992-09-29 Menetelmä pertaktiiniantigeenin tuottamiseksi ja sitä ilmentävä Pichia-mikro-organismi

Country Status (12)

Country Link
EP (2) EP0905251A1 (fi)
JP (1) JP3510624B2 (fi)
AT (1) ATE180013T1 (fi)
CA (1) CA2078858C (fi)
DE (1) DE69131226T2 (fi)
DK (1) DK0527752T3 (fi)
ES (1) ES2133284T3 (fi)
FI (1) FI104981B (fi)
GB (1) GB9007416D0 (fi)
GR (1) GR3030632T3 (fi)
NO (1) NO310150B1 (fi)
WO (1) WO1991015571A1 (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412207D0 (en) 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
GB8910570D0 (en) 1989-05-08 1989-06-21 Wellcome Found Acellular vaccine
US6197548B1 (en) 1990-04-02 2001-03-06 Medeva Pharma Limited Transformed Pichia expressing the pertactin antigen
GB9007657D0 (en) † 1990-04-04 1990-05-30 Connaught Lab Purification of a pertussis outer membrane protein(omp69)
GB9027901D0 (en) * 1990-12-21 1991-02-13 Wellcome Found Acellular vaccine
GB9106568D0 (en) * 1991-03-27 1991-05-15 Wellcome Found Recombinant antigen
US6444211B2 (en) 1991-04-03 2002-09-03 Connaught Laboratories, Inc. Purification of a pertussis outer membrane protein
GB9402832D0 (en) * 1994-02-15 1994-04-06 Smith Kline Beecham Biolog S A Novel process
ATE286511T1 (de) 1999-02-17 2005-01-15 Pfizer Prod Inc Fusionsproteine mit trägern welche eine doppelte immunantwort induzieren
ES2303833T3 (es) 2000-05-25 2008-09-01 Institut Pasteur Polipeptidos que contienen polimorfismos de las regiones repetidas de pertactina en bordetella pertussis, bordetella parapertussis y bordetella bronchiseptica, su uso en diagnostico y en composiciones inmunogenicas.
EP1174505A1 (en) * 2000-06-30 2002-01-23 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur (Poly)peptides for the preparation of vaccines against Bordetella pertussis and/or Bordetella parapertussis, vaccines based upon such (poly)peptides, and antibodies against such peptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ228948A (en) * 1988-05-13 1991-06-25 Phillips Petroleum Co Hbv particles containing s and pre-s 2 proteins and recombinant processes for their production in yeast cells

Also Published As

Publication number Publication date
FI924368A (fi) 1992-09-29
GB9007416D0 (en) 1990-05-30
NO923781L (no) 1992-09-29
CA2078858A1 (en) 1991-10-03
EP0527752A1 (en) 1993-02-24
EP0527752B1 (en) 1999-05-12
ES2133284T3 (es) 1999-09-16
CA2078858C (en) 2001-05-15
DE69131226T2 (de) 1999-09-23
GR3030632T3 (en) 1999-10-29
WO1991015571A1 (en) 1991-10-17
ATE180013T1 (de) 1999-05-15
JPH05505725A (ja) 1993-08-26
DE69131226D1 (de) 1999-06-17
EP0905251A1 (en) 1999-03-31
NO310150B1 (no) 2001-05-28
FI104981B (fi) 2000-05-15
NO923781D0 (no) 1992-09-29
JP3510624B2 (ja) 2004-03-29
DK0527752T3 (da) 1999-11-01

Similar Documents

Publication Publication Date Title
DK0733069T3 (da) Oprensede Primat CTLA-8-antigener og beslægtede reagenser
CA2114015A1 (en) Recombinant antibodies for human therapy
DK187889A (da) Dna-forbindelser og klonende vektorer, der koder for det monoklonale antistof ks1/4, samt chimere antistoffer afledt af ks1/4 og rettet mod et humant adenocarcinoma-antigen
FI924368A (fi) Expression av heterologiskt protein i jaest
FI934135A0 (fi) Ett foerfarande foer framstaellning av heme-proteiner
ATA192895A (de) Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen
DE59209129D1 (de) Verwendung von Antikörper enthaltenden Präparationen zur Immunsuppression
DE68918673D1 (de) IgG-bindendes Protein H, kodierendes Gen dafür und Verfahren zu seiner Herstellung.
FI90667C (fi) Menetelmä valmistaa uutta ihmisen tyypin I interferoniproteiinia
AU8298991A (en) Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins
ES2179824T3 (es) Anticuerpos humanizados reactivos contra el antigeno gpiib/iiia.
DE3688204D1 (de) Monoklonaler antikoerper gegen ein p21-bezuegliches dodekapeptid des ras-onkogens.
EP0299354A3 (en) Monoclonal antibodies against protein e7 of the human papilloma virus type 16, their production process and their use
DK0442372T3 (da) Forbedrede mærkede haptener, fremgangsmåde til deres fremstilling samt anvendelse af disse mærkede haptener ved immunoassays
DE3885975D1 (de) Monoklonale Antikörper gegen menschliche alpha-Atrialnatriüretic-Polypeptide und entsprechende Hybridome, deren Herstellung und Verwendung.
DE68914345D1 (de) Gamma-atriales, natriuretisches Polypeptid erkennende monoklonale Antikörper, solche Antikörper produzierende Hybridome und deren Herstellung und Verwendung.
DE69021921D1 (de) Monoklonale Antikörper gegen den C-Terminus von ANP.
PT87376A (pt) Monoklonaler antikoerper zur selektiven immunologischen bestimmung von intaktem prokollagen peptid (typ iii) und prokollagen (typ iii) in koerperfluessigkeiten
FR2656570B1 (fr) Gabarit d'apprentissage.
DE69128095D1 (de) Azelluläre impfstoffe
JPS5382434A (en) Surface covered plastic spectacle lens
EP0661541A3 (de) Verfahren zur Herstellung langzeitstabiler klarer Seren.

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: EVANS MEDICAL LIMITED

MA Patent expired